Since 2009, G-CON has lead the cleanroom industry, fulfilling pharmaceutical and biopharmaceutical needs and embracing new trends. G-CON designs, builds and installs prefabricated cleanroom PODs for a variety of dimensions and purposes, from laboratory environments to personalized medicines and even production process platforms.
As the leader in prefabricated turnkey cleanroom solutions, G-CON PODs represent a significant development in pharmaceutical and biopharmaceutical production. PODs provide the only system that is readily deployable, flexible, mobile and scalable in the cleanroom market.
Assessing The Impact Of COVID19 On The Biopharma Industry
In May 2020, G-Con conducted a survey to assess the impact of COVID-19 on the biopharmaceutical industry. We're giving you a summary of the results in the infographic. How does this compare to your organization's experience?
Evolution Of The POD: A Decade Inside The Box
In 2019, G-CON Manufacturing celebrated its 10 year anniversary. Here is an overview of how far our technology has progressed over those 10 years.
Delivery And Installation Of POD Facility To CAR-T Drug Manufacturer
In late 2018, G-CON began working with a global pharmaceutical company whose goal was to scale up their manufacturing operations in the US and Europe for an approved CAR-T product. Read how G-CON’s POD technology provided a solution in this schedule driven project.
Proposed vs. Actual Cleanroom Construction Costs And Delivery Timelines
When it comes to facilities or cleanroom infrastructures in the biopharmaceutical or cell/gene therapy industry, not only does management rely on what has been promised, but also the patients.
The Evolution Of Biopharmaceutical Facility Designs
In the lifecycle of pharmaceutical and biopharmaceutical commercial manufacturing, the one constant has been change. With the advent of modern therapeutics, large scale commercial manufacturing became common place.
How Do You Create the Ultimate Solution In Facility And Process Designs?
The broad range of technical capabilities along with prefabricated cleanroom PODs provides a true turnkey solution to biopharmaceutical manufacturers and CMO companies.
TCO Considerations For Biopharma Manufacturing Facilities
whether you’re building a plant for a small molecule drug or a biologic, you need to be able to do so faster and in a more agile manner than ever before.
Evaluating Pharma And Biopharma Facility Design Options
In the pharmaceutical and biopharmaceutical industry several factors have converged to change the landscape in regard to facilities.
Modular Facility Design Considerations For Bio Manufacturing Facilities
For many companies, flexibility, scheduling, and facility-size reduction are the key drivers around the attention given to modular facility design for biomanufacturing facilities.
Mobile Biocontainment Units Prevent Spread Of Transmissible Diseases
There exists two key methods for controlling serious outbreaks of transmissible diseases: therapeutic countermeasures and transmission control through isolation and containment.
How To Build A New Vaccine Facility Within Budget And Operational Deadlines
Once it has discovered a new drug, a drug manufacturer has a limited amount of time to reap the rewards of its invention before its patent expires and generic products enter the market.
Modular, Flexible, Or Both? Keys To Biomanufacturing Facility Design
In addition to traditional brick-and-mortar facilities, there are a range of alternative facility designs, including modular container, modular stick-built, isolator, and autonomous cleanroom POD designs